Helicobacter species and liver diseases: association or causation?

The Lancet Infectious Diseases

Volumn 8, Issue 4, 2008, Pages 254-260

  Pellicano, Rinaldo ^a   Ménard, Armelle ^b   Rizzetto, Mario ^a   Mégraud, Francis ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ISOLATION; HELICOBACTER; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CARCINOMA, HEPATOCELLULAR; DNA, BACTERIAL; HELICOBACTER; HELICOBACTER INFECTIONS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS;

EID: 40749115215     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(08)70066-5     Document Type: Review

References (84)

1. Parkin D. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Shistosomes, liver flukes and Helicobacter pylori (1994), IARC monographs, Lyon 177-243
3. Ward J., Fox J., Anver M., et al. Chronic active hepatitis and associated liver tumours in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86 (1994) 1222-1227
4. Fox J., Dewhirst F., Tully J., et al. Helicobacter hepaticus sp nov, a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32 (1994) 1238-1245
5. El-Serag H. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36 suppl 1 (2002) S74-S83
6. Nissen N., and Martin P. Hepatocellular carcinoma. The high-risk patient. J Clin Gastroenterol 35 suppl 2 (2002) S79-S85
7. Feitelson M., Pan J., and Lian Z. Early molecular and genetic determinants of primary liver malignancy. Surg Clin N Am 84 (2004) 339-354
8. Roberts L., and Gores G. Hepatocellular carcinoma. In: Yamada T., Alpers D., Kaplowitz N., Laine L., Owyang C., and Powell D. (Eds). Textbook of gastroenterology (2003), Lippincott Williams & Wilkins, Philadelphia 2491-2512
9. Houghton J., Stoicov C., Nomura S., et al. Gastric cancer originating from bone marrow-derived cells. Science 306 (2004) 1568-1571
10. Yu M., and Yuan J. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127 suppl 1 (2004) S72-S78
11. Smela M., Currier S., Bailey E., and Essigmann J. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 22 (2004) 535-545
12. El-Serag H. Hepatocellular carcinoma. An epidemiologic view. J Clin Gastroenterol 35 suppl 2 (2002) S72-S78
13. Fried M., Shiffman M., Reddy K., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
14. Min A., and Theise N. Prospects for cell-based therapies for liver disease. Panminerva Med 46 (2004) 43-48
15. Kuper H., Adami H., and Trichopoulos D. Infection: preventable cause of human cancer. J Int Med 248 (2000) 171-183
16. Alberti A., Chemello L., and Benvegnù L. Natural history of hepatitis C. J Hepatol 31 suppl 1 (1999) 17-24
17. Silini E., Bottelli R., Asti M., et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 111 (1996) 199-205
18. Wiese M., Berr F., Lafrenz M., Porst H., and Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
19. Barrett S., Goh J., Coughlan B., et al. The natural course of hepatitis C virus infection after 22 years in a unique homogeneous cohort: spontaneous viral clearance and chronic HCV infection. Gut 49 (2001) 423-430
20. Rodger A., Roberts S., Lanigan A., Bowden S., Brown T., and Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 32 (2000) 582-587
21. Thomas D., Astemborski J., Rai R., et al. The natural history of hepatitis C virus infection. Host, viral, and environmental factors. JAMA 284 (2000) 450-456
22. Seeff L. Natural history of chronic hepatitis C. Hepatology 36 suppl 1 (2002) S35-S46
23. Casiraghi M., De Paschale M., Romanò L., et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 39 (2004) 90-96
24. Koretz R., Abbey H., Coleman E., and Gitnick G. Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med 119 (1993) 110-115
25. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340 (1999) 1228-1233
26. Vogt M., Lang T., Frösner G., et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341 (1999) 866-870
27. Wiese M., Berr F., Lafrenz M., Porst H., and Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
28. Solnick J., and Schauer D. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 14 (2001) 59-97
29. Fox J., Li X., Yan L., et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent H hepaticus infection: a model of Helicobacter induced carcinogenesis. Infect Immun 64 (1996) 1548-1558
30. Fox J., Yan L., Shames B., Campbell J., Murphy J., and Li X. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 64 (1996) 3673-3681
31. Avenaud P., Le Bail K., Mayo K., et al. Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect Immun 71 (2003) 3667-3673
32. Ihrig M., Schrenzel M., and Fox J. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 155 (1999) 571-582
33. Rogers A., Boutin S., Whary M., et al. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 32 (2004) 668-677
34. Fox J., Yan L., Dewhirst F., et al. Helicobacter bilis sp nov, a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 33 (1995) 445-454
35. Fox J., Rogers A., Wharey M., et al. Helicobacter bilis-associated hepatitis in outbred mice. Comp Med 54 (2004) 571-577
36. Fox J., Drolet R., Higgins R., et al. Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 34 (1996) 2479-2482
37. Stanley J., Linton D., Burnens A., et al. Helicobacter pullorum sp nov-genotype and phenotype of a new species isolated from poultry and from human patients with gastroenteritis. Microbiology 140 (1994) 3441-3449
38. Fox J., Shen Z., Xu S., et al. Helicobacter marmotae sp nov isolated from livers of woodchucks and intestines of cats. J Clin Microbiol 40 (2002) 2513-2519
39. Shen Z., Xu S., Dewhirst F., et al. A novel enterohepatic species "Helicobacter mastomyrinus" isolated from the liver and intestine of rodents. Helicobacter 10 (2005) 59-70
40. Fox J., Handt L., Sheppard B., et al. Isolation of Helicobacter cinaedi from the colon, liver, and mesenteric lymph node of a rhesus monkey with chronic colitis and hepatitis. J Clin Microbiol 39 (2001) 1580-1585
41. Franklin C., Beckwith C., Livingston R., et al. Isolation of a novel Helicobacter species, Helicobacter cholecystus sp nov, from the gallbladders of Syrian hamsters with cholangiofibrosis and cetrilobular pancreatitis. J Clin Microbiol 34 (1996) 2952-2958
42. Zullo A., Hassan C., and Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liv Dis 35 (2003) 197-205
43. Vergara M., Calvet X., and Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 14 (2002) 717-722
44. Tiwari S., Khan A., Ibrahim M., Habeeb M., and Habibullah C. Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J Gastroenterol 12 (2006) 2181-2186
45. Figura N., Cetta F., Angelico M., et al. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H pylori antigens and genomic materials in bile: is it a risk factor for gallstone formation?. Dig Dis Sci 43 (1998) 854-862
46. Chen W., Li D., Cannan R., and Stubbs R. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis 35 (2003) 237-243
47. Silva C., Pereira-Lima F., Oliveira A., et al. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 41 (2003) 5615-5618
48. Fukuda K., Kuroki T., Tajima Y., et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 23 (2002) 1927-1931
49. Myung S., Kim M., Shin K., et al. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci 45 (2000) 1405-1412
50. Fallone C., Tran S., Semret M., Discepola F., Behr M., and Barkun A. Helicobacter DNA in bile: correlation with hepato-biliary diseases. Aliment Pharmacol Ther 17 (2003) 453-458
51. Kawaguchi M., Saito T., Ohno H., et al. Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol 31 (1996) 294-298
52. Fox J., Dewhirst F., Shen Z., et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 14 (1998) 755-763
53. Apostolov E., Abu Al-Soud W., Nilsson I., et al. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods. Scand J Gastroenterol 40 (2005) 1-7
54. Nilsson H., Taneera J., Castedal M., Glatz E., Olsson R., and Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hydridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Micriobiol 38 (2000) 1072-1076
55. Boomkens S., de Rave S., Pot R., et al. The role of Helicobacter spp in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis. FEMS 44 (2005) 221-225
56. Tanaka A., Prindville T., Gish R., et al. Are infections agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 31 (1999) 664-671
57. Avenaud P., Marais A., Monteiro L., et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89 (2000) 1431-1439
58. Ponzetto A., Pellicano R., Leone N., et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?. Med Hypotheses 54 (2000) 275-277
59. Nilsson H., Mulchandani R., Tranberg K., Stenram U., and Waldstrom T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 120 (2000) 323-324
60. Fan X.-G., Peng X.-N., Huang Y., Yakoob J., Wang Z.-M., and Chen Y.-P. Helicobacter species ribosomal DNA recovered from the liver tissue of Chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 35 (2002) 1555-1557
61. Coppola N., de Stefano G., Marrocco C., et al. Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer. Hepatology 36 (2002) 1300-1301
62. Verhoef C., Pot R., de Man R., et al. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 15 (2003) 1171-1174
63. Pellicano R., Mazzaferro V., Grigioni W., et al. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 10 (2004) 598-601
64. Ito K., Nakamura M., Toda G., Negishi M., Torii A., and Ohno T. Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 13 (2004) 221-227
65. Huang Y., Fan X., Wang Z., Zhou J., Tian X., and Li N. Identification of Helicobacter species in human liver samples of patients with primary hepatocellular carcinoma. J Clin Pathol 57 (2004) 1273-1277
66. Rocha M., Avenaud P., Ménard A., et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 54 (2005) 396-401
67. Boutin S., Rogers A., Shen Z., et al. Hepatic temporal gene expression profiling in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 32 (2004) 678-693
68. Vernucci M., Cerrato F., Besnard N., et al. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Oncogene 19 (2000) 6376-6385
69. Taylor N., Fox J., and Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H pylori and other Helicobacter species. J Med Microbiol 42 (1995) 48-52
70. Young V., Knox K., and Schauer D. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 68 (2000) 184-191
71. Avenaud P., Castroviejo M., Claret S., Rosenbaum J., Mégraud F., and Ménard A. Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Biochem Biophys Res Commun 318 (2004) 739-745
72. Taylor N., Ge Z., Shen Z., Dewhirst F., and Fox J. Cytolethal distending toxin: a potential virulence factor for Helicobacter cinaedi. J Infect Dis 188 (2003) 1892-1897
73. Ceelen L., Haesebrouck F., Favoreel H., Ducatelle R., and Decostere A. The cytolethal distending toxin among Helicobacter pullorum strains from human and poultry origin. Vet Microbiol 113 (2006) 45-53
74. Chien C., Taylor N., Ge Z., Schauer D., Young V., and Fox J. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 49 (2000) 525-534
75. Suerbaum S., Josenhans S., Sterzenbach T., et al. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci USA 100 (2003) 7901-7906
76. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
77. Pikarsky E., Porat R., Stein I., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
78. De Magalhães Queiroz D., and Santos A. Isolation of a Helicobacter strain from the human liver. Gastroenterology 121 (2001) 1023-1024
79. O'Rourke J., Solnick J., Neilan B., et al. Description of "Candidatus Helicobacter heilmannii" based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol 54 (2004) 2203-2211
80. Dewhirst F., Shen Z., Scimeca M., et al. Discordant 16S and 23S rRNA gene phylogenies for the genus Helicobacter: implications for phylogenetic inference and systematics. J Bacteriol 187 (2005) 6106-6118
81. Hanninen M., Utriainen M., Happonen I., and Dewhirst F. Helicobacter sp flexispira 16S rDNA taxa 1, 4 and 5 and Finnish porcine Helicobacter isolates are members of the species Helicobacter trogontum (taxon 6). Int J Syst Evol Microbiol 53 (2003) 425-433
82. Castéra L., Pedeboscq A., Rocha M., et al. Relationship between the presence of Helicobacter species in the liver and the severity of HCV-related liver disease: a prospective study. World J Gastroenterol 12 (2006) 7278-7284
83. Gasbarrini A., Carloni E., Gasbarrini G., and Chrisholm S. Helicobacter pylori and extragastric diseases-other Helicobacters. Helicobacter 9 suppl I (2004) 57-66
84. Hill B. The environment and disease: association or causation. Proc R Soc Med 58 (1965) 295-300